182 related articles for article (PubMed ID: 8536452)
21. The case for a lower dose pill. Assessing the impact of estrogen dose.
Brown S; Cropfield O
ORGYN; 1995; (2):36-9. PubMed ID: 12319251
[TBL] [Abstract][Full Text] [Related]
22. Factors influencing the reliability of oral contraceptives.
Hansen TH; Lundvall F
Acta Obstet Gynecol Scand; 1997 Jan; 76(1):61-4. PubMed ID: 9033246
[TBL] [Abstract][Full Text] [Related]
23. Cerebral thromboembolism among young women and men in Denmark 1977-1982.
Lidegaard O; Soe M; Andersen MV
Stroke; 1986; 17(4):670-5. PubMed ID: 3738950
[TBL] [Abstract][Full Text] [Related]
24. Oral contraceptives and venous thromboembolism: a case-control study designed to minimize detection bias.
Realini JP; Encarnacion CE; Chintapalli KN; Rees CR
J Am Board Fam Pract; 1997; 10(5):315-21. PubMed ID: 9297655
[TBL] [Abstract][Full Text] [Related]
25. Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use.
Pike MC; Henderson BE; Krailo MD; Duke A; Roy S
Lancet; 1983 Oct; 2(8356):926-30. PubMed ID: 6138501
[TBL] [Abstract][Full Text] [Related]
26. Cerebral thrombosis and oral contraceptives. A case-control study.
Lidegaard O; Kreiner S
Contraception; 1998 May; 57(5):303-14. PubMed ID: 9673837
[TBL] [Abstract][Full Text] [Related]
27. Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives.
Chie WC; Li CY; Huang CS; Chang KJ; Yen ML; Lin RS
Int J Cancer; 1998 Jul; 77(2):219-23. PubMed ID: 9650556
[TBL] [Abstract][Full Text] [Related]
28. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.
Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Büller HR; Vandenbroucke JP
Lancet; 1995 Dec; 346(8990):1593-6. PubMed ID: 7500751
[TBL] [Abstract][Full Text] [Related]
29. Oral contraceptives and breast cancer: a cooperative Italian study.
La Vecchia C; Negri E; Franceschi S; Talamini R; Amadori D; Filiberti R; Conti E; Montella M; Veronesi A; Parazzini F
Int J Cancer; 1995 Jan; 60(2):163-7. PubMed ID: 7829209
[TBL] [Abstract][Full Text] [Related]
30. Increased number of induced abortions in Norway after media coverage of adverse vascular events from the use of third-generation oral contraceptives.
Skjeldestad FE
Contraception; 1997 Jan; 55(1):11-4. PubMed ID: 9013055
[TBL] [Abstract][Full Text] [Related]
31. Oral contraceptives and venous thromboembolic disease: the findings from database studies in the United Kingdom and Germany.
Farmer RD; Lawrenson RA
Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 2):S78-86. PubMed ID: 9753314
[TBL] [Abstract][Full Text] [Related]
32. Contraceptive choices in women with coagulation disorders.
Comp PC; Zacur HA
Am J Obstet Gynecol; 1993 Jun; 168(6 Pt 2):1990-3. PubMed ID: 8512043
[TBL] [Abstract][Full Text] [Related]
33. Oral contraceptives, pregnancy and the risk of cerebral thromboembolism: the influence of diabetes, hypertension, migraine and previous thrombotic disease.
Lidegaard O
Br J Obstet Gynaecol; 1995 Feb; 102(2):153-9. PubMed ID: 7756208
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of smoking and oral contraception in a sample of Danish young women.
Jeune B; Wielandt H
Scand J Soc Med; 1991 Mar; 19(1):44-6. PubMed ID: 1925426
[TBL] [Abstract][Full Text] [Related]
35. Incidence of arterial disease among oral contraceptive users. Royal College of General Practitioners' Oral Contraception Study.
J R Coll Gen Pract; 1983 Feb; 33(247):75-82. PubMed ID: 6864638
[TBL] [Abstract][Full Text] [Related]
36. [Cardiovascular risks of oral contraceptives: dose-response relationship].
Kelleher CC
Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
[TBL] [Abstract][Full Text] [Related]
37. [Thromboembolic attacks in the central nervous system and P-pills].
Lidegaard O
Ugeskr Laeger; 1982 Sep; 144(38):2769-72. PubMed ID: 7157502
[TBL] [Abstract][Full Text] [Related]
38. Oral contraceptive risks: a realistic appraisal.
Bressler R; Durand JL
Drug Ther (NY); 1979 Oct; 9(10):81-95. PubMed ID: 12279276
[TBL] [Abstract][Full Text] [Related]
39. Risk factors for fatal venous thromboembolism in young women: a case-control study.
Thorogood M; Mann J; Murphy M; Vessey M
Int J Epidemiol; 1992 Feb; 21(1):48-52. PubMed ID: 1544757
[TBL] [Abstract][Full Text] [Related]
40. Epidemiology of endometriosis in women attending family planning clinics.
Vessey MP; Villard-Mackintosh L; Painter R
BMJ; 1993 Jan; 306(6871):182-4. PubMed ID: 8338516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
